Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
COURT-FORTUNE, Isabelle
ENDOTHELION, NCT02377271 / 2014-000848-14: Study Group: Effect of Bosentan in NAION Patients	Recruiting	3	86	Europe	bosentan, placebo	University Hospital, Grenoble	Ischemic Optic Neuropathy	12/23	12/25
VOILAGE, NCT02358811: Evaluation of the Impact of Sleep Apnea on Cerebral Volumetry According to Age	Terminated	N/A	69	Europe	Magnetic resonance imaging (MRI), Cognitive assessment	Centre Hospitalier Universitaire de Saint Etienne	Obstructive Sleep Apnea (SAOS), Aging	03/23	04/23
FEASSON, Séverine SF
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
COURT-FORTUNE, Isabelle
ENDOTHELION, NCT02377271 / 2014-000848-14: Study Group: Effect of Bosentan in NAION Patients	Recruiting	3	86	Europe	bosentan, placebo	University Hospital, Grenoble	Ischemic Optic Neuropathy	12/23	12/25
VOILAGE, NCT02358811: Evaluation of the Impact of Sleep Apnea on Cerebral Volumetry According to Age	Terminated	N/A	69	Europe	Magnetic resonance imaging (MRI), Cognitive assessment	Centre Hospitalier Universitaire de Saint Etienne	Obstructive Sleep Apnea (SAOS), Aging	03/23	04/23
FEASSON, Séverine SF
No trials found